Carbonated Saline Delivery Device for Lower Body Cavity Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for lower body cavity ailments, such as urinary, vaginal, and intestinal issues, often require invasive methods and may not effectively address infection reduction, cleansing, and post-surgical care, particularly in terms of delivering therapeutic agents directly to these areas.
Innovation Solution
A method and device utilizing a saline solution infused with dissolved carbon dioxide and carbonic acid, with optional additional active components, delivered through a flow-regulating device to treat lower body cavities, ensuring controlled release and distribution, enhancing antibacterial effects and tissue healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If invasive methods are used to treat lower body cavity ailments, then treatment effectiveness may be improved, but patient comfort and safety deteriorate
Solution Approach 1:
The patent changes the physical state and composition parameters of the treatment medium by dissolving carbon dioxide in saline solution to create carbonated saline. This chemical parameter change enhances the antibacterial effectiveness (through carbonic acid formation) and tissue penetration while maintaining a non-invasive application method, thus improving treatment reliability without increasing patient discomfort or safety risks
Solution Approach 2:
The patent combines multiple substances (saline, carbon dioxide, and optionally other therapeutic agents) into a composite treatment solution. This composite material approach integrates the moisturizing and cleansing properties of saline with the antibacterial properties of carbonic acid, achieving effective treatment of lower body cavity ailments through a single non-invasive application
2Measurement precision
If therapeutic agents are delivered directly to lower body cavities, then treatment precision is improved, but delivery system complexity increases
Solution Approach 1:
The patent uses carbonated saline as an intermediary medium that can be easily delivered through simple sprayers or irrigators. This intermediary solution carries therapeutic agents (including carbonic acid and optional additives) to the target area in lower body cavities, achieving precise treatment without requiring complex delivery systems or invasive procedures
3Reliability
If carbon dioxide and saline mixture is used for treatment, then antibacterial effectiveness is improved, but treatment protocol complexity increases
Solution Approach 1:
The patent employs carbon dioxide dissolved in saline that automatically forms carbonic acid in the treatment solution, providing self-generated antibacterial action. The carbonated saline solution inherently contains the therapeutic agent (carbonic acid) formed through the chemical reaction of CO2 with water, eliminating the need for separate administration steps or complex protocols while maintaining high antibacterial effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides effective infection reduction, cleansing, and post-surgical treatment for lower body cavity ailments by leveraging the antibacterial properties of carbonic acid and the moisturizing effects of saline, with improved delivery and absorption, offering rapid wound healing and enhanced safety profiles.
Implementation Method 1
dissolved carbon dioxide gas, with some carbonic acid formed when the carbon dioxide dissolves in the saline
Implementation Method 2
carbonic acid as an active antibacterial component, wherein the carbonic acid is formed when the carbon dioxide dissolves in the saline
Data Source
AI summary
A method of treatment for mixed carbon dioxide, carbonic acid, saline and optional active additives for treating lower body cavity ailments includes delivery of dosage of the treatment at specified flow rates, using a) main housing having a hollow central area containing the dosage; b) a dosage dispenser head located at the distal end of the main housing, and having at least one flow channel for movement of the dosage from the main housing through the dosage dispenser head and to external of the dosage dispenser head; c) a dosage release control component located between the main housing and the dosage dispenser head to permit flow of the dosage through the dosage dispenser head in response to increased pressure against the dosage; and d) a pressure-changing moveable component on the main housing.